In today's ACT Brief, we recap key themes from DIA 2026 on operational priorities and regulatory shifts, examine ...

The China Food and Drug Administration (CFDA) has released a provisional document regarding the validation of clinical trial data. Under the model, CFDA’s audit team will conduct on-site assessments ...

In today's ACT Brief, we examine HHS coordinated effort to restore US clinical research leadership, two decades of rising ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

For years, payment integrity was built around simple assumptions: errors can be fixed after payment. In today’s environment of rising medical costs and accelerating claims volume, that approach isn’t ...

Clinical Affairs plays a central role in ensuring that CGM promotional claims are accurate, evidence-based, and compliant. By ...

With research that requires the use of human subjects, investigators and coordinators must not only respect the rights of their participants, but they must actively protect their safety and dignity as ...

Artificial intelligence is no longer an emerging technology—it is an embedded reality shaping the way we live, govern and do business. From predictive healthcare to autonomous defense systems, AI is ...